Valuation: Crossject

Market Cap 71.32M 80.34M 66.74M 60.5M 114M 7.75B 115M 802M 312M 3.95B 302M 295M 12.7B P/E 2026 *
3.2x
P/E 2027 * 2.52x
Enterprise Value 53.42M 60.18M 49.99M 45.31M 85.58M 5.8B 86.2M 600M 234M 2.96B 226M 221M 9.51B EV / Sales 2026 *
0.88x
EV / Sales 2027 * 0.37x
Free-Float
92.46%
Yield 2026 *
-
Yield 2027 * -
1 day+2.75%
1 week-0.30%
Current month-2.46%
1 month-3.86%
3 months-22.64%
6 months-32.87%
Current year-38.54%
1 week 1.29
Extreme 1.288
1.41
1 month 1.19
Extreme 1.188
1.44
Current year 1.19
Extreme 1.188
2.58
1 year 1.19
Extreme 1.188
2.7
3 years 0.72
Extreme 0.7199
5.96
5 years 0.72
Extreme 0.7199
5.96
10 years 0.72
Extreme 0.7199
7.25
Manager TitleAgeSince
Chief Executive Officer 63 2001-08-07
Director of Finance/CFO - 2026-03-24
Corporate Officer/Principal - 2024-08-19
Director TitleAgeSince
Chairman 67 2009-06-25
Director/Board Member 67 -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
7/4/25 Buy

Director

13,386 0.0266%
7/1/25 Buy

Director

50 0.0001%
7/1/25 Buy

Director

337 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
+2.75%-0.30%-37.10%-64.06% 79.95M
-1.89%-2.51%-26.41%+1.58% 173B
-1.71%-0.29%-11.78%+14.08% 113B
-2.30%+0.05%-23.85%+4.91% 109B
+1.52%+1.45%-46.87%-10.58% 74.44B
-0.46%+2.45%+3.22%+71.41% 60.1B
+3.27%+7.25%+18.14%+67.16% 51.87B
-0.05%-0.48%-5.67%-30.99% 49.21B
-2.66%-3.73%-18.20%+15.14% 41.52B
-4.18%-3.66%+25.78%+0.30% 32.79B
Average -0.53%+0.86%-12.27%+6.90% 70.52B
Weighted average by Cap. -1.05%+0.42%-15.68%+12.04%

Financials

2026 *2027 *
Net sales 60.8M 68.49M 56.9M 51.57M 97.4M 6.6B 98.1M 683M 266M 3.37B 257M 252M 10.83B 65.2M 73.45M 61.01M 55.3M 104M 7.08B 105M 733M 285M 3.61B 276M 270M 11.61B
Net income 28.3M 31.88M 26.48M 24M 45.33M 3.07B 45.66M 318M 124M 1.57B 120M 117M 5.04B 35.6M 40.1M 33.31M 30.2M 57.03M 3.87B 57.44M 400M 156M 1.97B 151M 147M 6.34B
Net Debt -17.9M -20.16M -16.75M -15.18M -28.67M -1.94B -28.88M -201M -78.25M -992M -75.69M -74.07M -3.19B -47M -52.95M -43.98M -39.87M -75.29M -5.1B -75.83M -528M -205M -2.6B -199M -194M -8.37B
Projected Income Statement - Annual - Crossject
Logo Crossject
Crossject specializes in manufacturing and marketing needleless drug self-injection. The group provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.
Employees
99
Date Price Change Volume
26-10-06 €1.346 +2.75% 204,373
26-10-05 €1.310 0.00% 62,564
26-10-02 €1.310 -2.96% 119,215
26-10-01 €1.350 -2.17% 88,486
26-09-30 €1.380 +2.22% 85,077
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Ratings Surperformance© - Crossject
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.310EUR
Average target price
4.400EUR
Spread / Average Target
+235.88%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Crossject
  1. Stock Market
  2. Stocks
  3. ALCJ Stock